))
Ann Yeh on paediatric-onset multiple sclerosis
Manage episode 498515893 series 2902433
Вміст надано The Lancet Group. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією The Lancet Group або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Paediatric-onset multiple sclerosis before the age of 18 years, although uncommon, is associated with a higher disease burden than adult onset MS, early and progressive motor and cognitive disability, and high levels of depression and fatigue. In this episode Ann Yeh, Professor of Paediatrics and neurologist in Toronto, Canada, highlights the global considerations in preventing MS disease progression in young people with MS, including achieving global equity in access to diagnostics, specialist services, and highly-effective disease modifying therapies for adolescents and young adults with MS.
Read the Review in this month's issue here:
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(24)00047-6/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanchi
Real-life benefits of high-efficacy therapies for children with multiple sclerosis https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(24)00074-9/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanchi
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://www.linkedin.com/company/lanchi/
https://youtube.com/thelancettv
26 епізодів
Поширити
